{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:16:59Z","timestamp":1772165819854,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82471546"],"award-info":[{"award-number":["82471546"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangzhou Health Science and Technology Project","award":["20231A010038"],"award-info":[{"award-number":["20231A010038"]}]},{"name":"Innovative Clinical Technique of Guangzhou"},{"name":"Guangzhou Research-oriented Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-025-07413-y","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:15:26Z","timestamp":1759914926000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Validation and clinical application of the Chinese version of the rapid response scale"],"prefix":"10.1186","volume":"25","author":[{"given":"Ziying","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zerui","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuping","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"7413_CR1","doi-asserted-by":"publisher","first-page":"e073823","DOI":"10.1136\/bmj-2022-073823","volume":"386","author":"C Njenga","year":"2024","unstructured":"Njenga C, Ramanuj PP, de Magalh\u00e3es FJC, Pincus HA. New and emerging treatments for major depressive disorder. BMJ. 2024;386:e073823.","journal-title":"BMJ"},{"issue":"9","key":"7413_CR2","doi-asserted-by":"publisher","first-page":"826","DOI":"10.4088\/JCP.v63n0913","volume":"63","author":"RMA Hirschfeld","year":"2002","unstructured":"Hirschfeld RMA, Montgomery SA, Aguglia E, Amore M, Delgado PL, Gastpar M, et al. Partial response and nonresponse to antidepressant therapy: current approaches and treatment options. J Clin Psychiatry. 2002;63(9):826\u201337.","journal-title":"J Clin Psychiatry"},{"key":"7413_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jpsychires.2021.09.002","volume":"143","author":"JD Di Vincenzo","year":"2021","unstructured":"Di Vincenzo JD, Lipsitz O, Rodrigues NB, Lee Y, Gill H, Kratiuk K, et al. Ketamine monotherapy versus adjunctive ketamine in adults with treatment-resistant depression: results from the Canadian rapid treatment centre of excellence. J Psychiatr Res. 2021;143:209\u201314.","journal-title":"J Psychiatr Res"},{"issue":"6","key":"7413_CR4","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1001\/jamapsychiatry.2023.4685","volume":"81","author":"ST Aaronson","year":"2024","unstructured":"Aaronson ST, van der Vaart A, Miller T, LaPratt J, Swartz K, Shoultz A, et al. Single-dose synthetic psilocybin with psychotherapy for treatment-resistant bipolar type II major depressive episodes: a nonrandomized open-label trial. JAMA Psychiatr. 2024;81(6):555\u201362.","journal-title":"JAMA Psychiatr"},{"key":"7413_CR5","unstructured":"Wc AJXQRLVP, Cm D et al. C,. Esketamine Monotherapy in Adults With Treatment-Resistant Depression: A Randomized Clinical Trial. JAMA Psychiatry. 2025 Feb 7 [cited 2025 Jul 27]; Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/40601310\/"},{"key":"7413_CR6","unstructured":"Jb S, M F, C EDLX et al. M, G DB,. Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study. Biol Psychiatry. 2016 Sep 15 [cited 2025 Jul 27];80(6). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26707087\/"},{"key":"7413_CR7","doi-asserted-by":"publisher","first-page":"e52764","DOI":"10.2196\/52764","volume":"13","author":"D Holley","year":"2025","unstructured":"Holley D, Brooks A, Hartz M, Rao S, Zaubler T. MHealth-augmented care for reducing depression symptom severity among patients with chronic pain: exploratory, retrospective cohort study. JMIR Mhealth Uhealth. 2025;13:e52764.","journal-title":"JMIR Mhealth Uhealth"},{"issue":"1","key":"7413_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/wps.21263","volume":"24","author":"UH Schmidt","year":"2025","unstructured":"Schmidt UH, Claudino A, Fern\u00e1ndez-Aranda F, Giel KE, Griffiths J, Hay PJ, et al. The current clinical approach to feeding and eating disorders aimed to increase personalization of management. World Psychiatry. 2025;24(1):4\u201331.","journal-title":"World Psychiatry"},{"key":"7413_CR9","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382\u20139.","journal-title":"Br J Psychiatry"},{"issue":"12","key":"7413_CR10","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.jpsychires.2009.02.001","volume":"43","author":"G Santen","year":"2009","unstructured":"Santen G, Danhof M, Della Pasqua O. Sensitivity of the Montgomery Asberg depression rating scale to response and its consequences for the assessment of efficacy. J Psychiatr Res. 2009;43(12):1049\u201356.","journal-title":"J Psychiatr Res"},{"issue":"1","key":"7413_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0022-3956(99)00037-0","volume":"34","author":"D Faries","year":"2000","unstructured":"Faries D, Herrera J, Rayamajhi J, DeBrota D, Demitrack M, Potter WZ. The responsiveness of the Hamilton depression rating scale. J Psychiatr Res. 2000;34(1):3\u201310.","journal-title":"J Psychiatr Res"},{"issue":"6","key":"7413_CR12","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.comppsych.2005.03.001","volume":"46","author":"HG Ruh\u00e9","year":"2005","unstructured":"Ruh\u00e9 HG, Dekker JJ, Peen J, Holman R, Jonghe FD. Clinical use of the Hamilton depression rating scale: is increased efficiency possible? A post hoc comparison of Hamilton depression rating scale, Maier and Bech subscales, clinical global impression, and symptom checklist-90 scores. Compr Psychiatry. 2005;46(6):417\u201327.","journal-title":"Compr Psychiatry"},{"issue":"6","key":"7413_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/00004850-200211000-00003","volume":"17","author":"A Khan","year":"2002","unstructured":"Khan A, Khan SR, Shankles EB, Polissar NL. Relative sensitivity of the Montgomery-Asberg depression rating scale, the Hamilton depression rating scale and the clinical global impressions rating scale in antidepressant clinical trials. Int Clin Psychopharmacol. 2002;17(6):281\u20135.","journal-title":"Int Clin Psychopharmacol"},{"key":"7413_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s10488-024-01349-3","author":"J Barber","year":"2024","unstructured":"Barber J, Resnick SG. Can measurement-based care reduce burnout in mental health clinicians?? Adm Policy Ment Health. 2024. https:\/\/doi.org\/10.1007\/s10488-024-01349-3.","journal-title":"Adm Policy Ment Health"},{"issue":"1","key":"7413_CR15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1017\/S0033291703001107","volume":"34","author":"MH Trivedi","year":"2004","unstructured":"Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T, et al. The inventory of depressive symptomatology, clinician rating (IDS-C) and self-report (IDS-SR), and the quick inventory of depressive symptomatology, clinician rating (QIDS-C) and self-report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med. 2004;34(1):73\u201382.","journal-title":"Psychol Med"},{"key":"7413_CR16","doi-asserted-by":"publisher","first-page":"1135828","DOI":"10.3389\/fpsyt.2023.1135828","volume":"14","author":"C Yavorsky","year":"2023","unstructured":"Yavorsky C, Ballard E, Opler M, Sedway J, Targum SD, Lenderking W. Recommendations for selection and adaptation of rating scales for clinical studies of rapid-acting antidepressants. Front Psychiatry. 2023;14:1135828.","journal-title":"Front Psychiatry"},{"key":"7413_CR17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jad.2021.03.053","volume":"288","author":"RS McIntyre","year":"2021","unstructured":"McIntyre RS, Rodrigues NB, Lipsitz O, Lee Y, Cha DS, Gill H, et al. Validation of the mcintyre and rosenblat rapid response scale (MARRRS) in adults with treatment-resistant depression receiving intravenous ketamine treatment. J Affect Disord. 2021;288:210\u20136.","journal-title":"J Affect Disord"},{"key":"7413_CR18","doi-asserted-by":"crossref","unstructured":"Zhou Y, Wang CY, Lan XF, et al. Cognitive function mediates the anti-suicide effect of repeated intravenous ketamine in adult patients with suicidal ideation. Front Psychiatry. 2022;13:779326 .","DOI":"10.3389\/fpsyt.2022.779326"},{"issue":"7","key":"7413_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare10071299","volume":"10","author":"CS Brune","year":"2022","unstructured":"Brune CS, Toporowski G, R\u00f6lfing JD, Gosheger G, Fresen J, Frommer A, et al. German translation and cross-cultural adaptation of the limb Deformity-Scoliosis research society (LD-SRS) questionnaire. Healthcare. 2022;10(7):1299.","journal-title":"Healthcare"},{"key":"7413_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2022.103104","volume":"73","author":"XM Wang","year":"2022","unstructured":"Wang XM, Ma HY, Zhong J, Huang XJ, Yang CJ, Sheng DF, et al. A Chinese adaptation of six items, self-report Hamilton depression scale: factor structure and psychometric properties. Asian J Psychiatr. 2022;73:103104.","journal-title":"Asian J Psychiatr"},{"issue":"4","key":"7413_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.1927","volume":"31","author":"S Borentain","year":"2022","unstructured":"Borentain S, Gogate J, Williamson D, Carmody T, Trivedi M, Jamieson C, et al. Montgomery-\u00c5sberg depression rating scale factors in treatment-resistant depression at onset of treatment: derivation, replication, and change over time during treatment with esketamine. Int J Methods Psychiatr Res. 2022;31(4):e1927.","journal-title":"Int J Methods Psychiatr Res"},{"issue":"5","key":"7413_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12051744","volume":"12","author":"A Rajewska-Rager","year":"2023","unstructured":"Rajewska-Rager A, Dmitrzak-Weglarz M, Lepczynska N, Kapelski P, Pawlak J, Szczepankiewicz A, et al. Dimensions of the Hamilton depression rating scale correlate with impulsivity and personality traits among youth patients with depression. J Clin Med. 2023;12(5):1744.","journal-title":"J Clin Med"},{"key":"7413_CR23","doi-asserted-by":"crossref","unstructured":"Fu HL, Si LL, Guo R. What is the optimal cut-off point of the 10-item center for epidemiologic studies depression scale for screening depression among Chinese individuals aged 45 and over? An exploration using latent profile analysis. [J] .Front Psychiatry. 2022;13:820777.","DOI":"10.3389\/fpsyt.2022.820777"},{"key":"7413_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.1483","author":"B Falissard","year":"2015","unstructured":"Falissard B, Sapin C, Loze JY, Landsberg W, Hansen K. Defining the minimal clinically important difference (MCID) of the Heinrichs\u2013carpenter quality of life scale (QLS). Int J Methods Psychiatr Res. 2015. https:\/\/doi.org\/10.1002\/mpr.1483.","journal-title":"Int J Methods Psychiatr Res"},{"key":"7413_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jad.2021.05.041","volume":"292","author":"M von Glischinski","year":"2021","unstructured":"von Glischinski M, von Brachel R, Thiele C, Hirschfeld G. Not sad enough for a depression trial? A systematic review of depression measures and cut points in clinical trial registrations. J Affect Disord. 2021;292:36\u201344.","journal-title":"J Affect Disord"},{"key":"7413_CR26","doi-asserted-by":"publisher","first-page":"1289630","DOI":"10.3389\/fpsyt.2024.1289630","volume":"15","author":"G Capodilupo","year":"2024","unstructured":"Capodilupo G, Blattner R, Must A, Navarro SG, Opler M. A qualitative investigation of the Montgomery-\u00c5sberg depression rating scale: discrepancies in rater perceptions and data trends in remote assessments of rapid-acting antidepressants in treatment resistant depression. Front Psychiatry. 2024;15:1289630.","journal-title":"Front Psychiatry"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07413-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-07413-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07413-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:15:30Z","timestamp":1759914930000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-025-07413-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7413"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-07413-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6789022\/v1","asserted-by":"object"}]},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"31 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Participants were recruited from The Affiliated Brain Hospital, Guangzhou Medical University, where they completed the entire treatment process and clinical evaluations. This study was approved by the Clinical Research Ethics Committee of The Affiliated Brain Hospital, Guangzhou Medical University (2021073). The program was conducted according to the principles of the Declaration of Helsinki. Prior to joining the treatment program, all participants gave written informed consent to participate in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"944"}}